Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Benign Pigmented Lesions
Total 0 results
Nothing found
Sponsors and Collaborators
Hospital Durand, Argentina
Eurofins Genoma
Everett Meyer
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Kupfer, David J., M.D.
Neurophth Therapeutics Inc
Korean Society of Spine Surgery
Mª Victoria Maestre Sanchez
ASST Cremona, Cremona
iCAD
Hospital ASEPEYO Sant Cugat
Nacuity Pharmaceuticals, Inc.
Agency for Science, Technology and Research
Aptis Medical
Alma Lasers Inc.
RMIT University, Melbourne, Australia
Apollo Neuroscience, Inc.
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
GFI
View Full List
Medical Conditions
Social Anxiety
Hospital Acquired Pressure Ulcer
STEMI - ST-segment Elevation Myocardial Infarction
Renal Function Disorder
PD-1 Refractory Advanced Melanoma
Artificial Pancreas
Age-related Hearing Loss
Post Covid-19 Condition
LOW OVARIAN RESPONSE
Neck Mass
Decay
Anatomic Stage 2A Breast Cancer AJCC v8
Extraarticular Fracture
Sporadic
Accuracy and Precision of Noninvasive Measurement
Anaplastic Large-cell Lymphoma
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Dislocation, Shoulder
Surgical Patient
Optimys Femoral Stem
View Full List
Drug Interventions
TPN-101
Letrozole
Intravenous deferiprone
Capecitabine/cisplatin
Capecitabine and IMRT (if randomized to this arm)
Standard of care (SOC) for COVID-19
Anticholinergic
MLN2480
RDX227675
Intravenous Formulation of PD-0332991
Fospropofol disodium, propofol
OnabotulinumtoxinA
Midazolam
Oxycodone/acetaminophen 5/325 mg
GLPG1837 multiple ascending doses
Desvenlafaxine
PD-1/PD-L1 inhibitor
Camptosar
Olopatadine
THC
View Full List
CROs by country
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cambodia
Contract Research Organizations in Dominican Republic
Contract Research Organizations in Hungary
Contract Research Organizations in Italy
Contract Research Organizations in Jamaica
Contract Research Organizations in Lithuania
Contract Research Organizations in Mauritius
Contract Research Organizations in Pakistan
Contract Research Organizations in Portugal
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Zambia
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Lithuania
PSI
Parexel
Medfiles
GCT (Global Clinical Trials)
Biomapas
SGS
Comac Medical
SanaClis
Dokumeds
All CROs in Lithuania
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe